Labuxtinib

Labuxtinib

SCHEMBL20844934

Cc1ccc(-c2noc([C@H]3CC3F)n2)cc1NC(=O)c1cnc2ccccn12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIT P10721 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Labuxtinib SCHEMBL24508232 1.00 KIT (1.00) KIT
Labuxtinib SCHEMBL14738734 1.00 KIT (1.00) KIT
Labuxtinib SCHEMBL14738252 1.00 KIT (1.00) KIT
Labuxtinib SCHEMBL14751407 1.00 KIT (1.00) KIT
Labuxtinib SCHEMBL14739429 1.00 KIT (1.00) KIT
Labuxtinib SCHEMBL29562904 0.99 KIT (0.98) KIT
Labuxtinib SCHEMBL29441810 0.95 KIT (0.91) KIT
SCHEMBL14738439 0.92 KIT (1.00) KIT
SCHEMBL27336503 0.91 KIT (0.84) KIT
SCHEMBL14738475 0.91 KIT (1.00) KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751102-B1 COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS NOVARTIS AG (CH) 2019-03-27 EP disclosed